2025-08-04 – Press Releases – www.prnewswire.com
BEIJING, Aug. 4, 2025 /PRNewswire/ — Raytone Biotech, a biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of RTP-008 during Q2 2025. RTP-008 is a bioabsorbable tacrolimus lacrimal…
